Literature DB >> 9751486

Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats.

R T Turner1, G L Evans, J M Cavolina, B Halloran, E Morey-Holton.   

Abstract

Gonadal insufficiency and reduced mechanical usage are two important risk factors for osteoporosis. The beneficial effects of PTH therapy to reverse the estrogen deficiency-induced bone loss in the laboratory rat are well known, but the influence of mechanical usage in this response has not been established. In this study, the effects of programed administration of PTH on cancellous bone volume and turnover at the proximal tibial metaphysis were determined in hindlimb-unloaded, ovariectomized (OVX), 3-month-old Sprague-Dawley rats. PTH was administered to weight-bearing and hindlimb-unloaded OVX rats with osmotic pumps programed to deliver 20 microg human PTH (approximately 80 microg/kg x day) during a daily 1-h infusion for 7 days. Compared with sham-operated rats, OVX increased longitudinal and radial bone growth, increased indexes of cancellous bone turnover, and resulted in net resorption of cancellous bone. Hindlimb unloading of OVX rats decreased longitudinal and radial bone growth, decreased osteoblast number, increased osteoclast number, and resulted in a further decrease in cancellous bone volume compared with those in weight-bearing OVX rats. Programed administration of PTH had no effect on either radial or longitudinal bone growth in weight-bearing and hindlimb-unloaded OVX rats. PTH treatment had dramatic effects on selected cancellous bone measurements; PTH maintained cancellous bone volume in OVX weight-bearing rats and greatly reduced cancellous bone loss in OVX hindlimb-unloaded rats. In the latter animals, PTH treatment prevented the hindlimb unloading-induced reduction in trabecular thickness, but the hormone was ineffective in preventing either the increase in osteoclast number or the loss of trabecular plates. Importantly, PTH treatment increased the retention of a baseline flurochrome label, osteoblast number, and bone formation in the proximal tibial metaphysis regardless of the level of mechanical usage. These findings demonstrate that programed administration of PTH is effective in increasing osteoblast number and bone formation and has beneficial effects on bone volume in the absence of weight-bearing and gonadal hormones. We conclude that the actions of PTH on cancellous bone are independent of the level of mechanical usage.

Entities:  

Keywords:  NASA Discipline Musculoskeletal; Non-NASA Center

Mesh:

Substances:

Year:  1998        PMID: 9751486     DOI: 10.1210/endo.139.10.6227

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

Review 1.  Stemming bone loss by suppressing apoptosis.

Authors:  J M Hock
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Proteoglycan 4: a dynamic regulator of skeletogenesis and parathyroid hormone skeletal anabolism.

Authors:  Chad M Novince; Megan N Michalski; Amy J Koh; Benjamin P Sinder; Payam Entezami; Matthew R Eber; Glenda J Pettway; Thomas J Rosol; Thomas J Wronski; Ken M Kozloff; Laurie K McCauley
Journal:  J Bone Miner Res       Date:  2012-01       Impact factor: 6.741

3.  Expression of PDGF-beta receptor, EGF receptor, and receptor adaptor protein Shc in rat osteoblasts during spaceflight.

Authors:  H Akiyama; S Kanai; M Hirano; H Shimokawa; H Katano; C Mukai; S Nagaoka; S Morita; Y Kumei
Journal:  Mol Cell Biochem       Date:  1999-12       Impact factor: 3.396

Review 4.  Influence of body weight on bone mass, architecture and turnover.

Authors:  Urszula T Iwaniec; Russell T Turner
Journal:  J Endocrinol       Date:  2016-06-27       Impact factor: 4.286

5.  Amelioration of type I diabetes-induced osteoporosis by parathyroid hormone is associated with improved osteoblast survival.

Authors:  Katherine J Motyl; Laurie K McCauley; Laura R McCabe
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

6.  Parathyroid hormone regulates osteoblast differentiation in a Wnt/β-catenin-dependent manner.

Authors:  Ye Tian; Ying Xu; Qin Fu; Ming He
Journal:  Mol Cell Biochem       Date:  2011-05-01       Impact factor: 3.396

7.  Low dose parathyroid hormone maintains normal bone formation in adult male rats during rapid weight loss.

Authors:  Russell T Turner; Urszula T Iwaniec
Journal:  Bone       Date:  2011-01-05       Impact factor: 4.398

8.  Changes in the gene expression pattern induced by 2-methoxyestradiol in the mouse uterus.

Authors:  Ramiro J Rincón-Rodríguez; María L Oróstica; Patricia Díaz; Patricia Reuquén; Hugo Cárdenas; Pedro A Orihuela
Journal:  Endocrine       Date:  2013-03-15       Impact factor: 3.633

9.  Prepubertal OVX increases IGF-I expression and bone accretion in C57BL/6J mice.

Authors:  Kristen E Govoni; Jon E Wergedal; Robert B Chadwick; Apurva K Srivastava; Subburaman Mohan
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-09-23       Impact factor: 4.310

10.  Signs of irreversible architectural changes occur early in the development of experimental osteoporosis as assessed by in vivo micro-CT.

Authors:  G M Campbell; H R Buie; S K Boyd
Journal:  Osteoporos Int       Date:  2008-03-29       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.